Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a gene predict leukemia relapse in kids?

NCT ID NCT06649253

First seen Jan 09, 2026 · Last updated May 22, 2026 · Updated 19 times

Summary

This study looks at why some children with B-cell acute lymphoblastic leukemia (B-ALL) relapse after treatment. Researchers will collect blood and bone marrow samples from 50 newly diagnosed children at three key times during therapy. They aim to understand how a protein called CD9, which helps leukemia cells move and stick, is regulated and whether it can serve as a marker for relapse risk. The study does not test a new treatment but seeks to improve future care by identifying those at higher risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOBLASTIC, ACUTE, PEDIATRIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Angers

    RECRUITING

    Angers, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Brest

    RECRUITING

    Brest, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Rennes

    RECRUITING

    Rennes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.